Accumulating evidence indicates that obesity is closely associated with an increased risk of
metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and …

Obesity, a worldwide epidemic, confers increased risk for multiple serious conditions,
including type 2 diabetes, cardiovascular diseases, nonalcoholic fatty liver disease and …

Obesity is the accumulation of abnormal or excessive fat that may interfere with the
maintenance of an optimal state of health. The excess of macronutrients in the adipose …

Obesity plays a causative role in the pathogenesis of the metabolic syndrome. Adipokines
may link obesity to its co-morbidities. Most adipokines with pro-inflammatory properties are …

Adipokines are currently widely studied cellular signaling proteins produced by adipose
tissue and involved in various processes, including inflammation; energy and appetite …

Obesity is frequently associated with chronic inflammation, metabolic and vascular
alterations which predispose to the development of the Metabolic Syndrome (MetS) …

Obesity, a social problem worldwide, is characterized by an increase in body weight that
results in excessive fat accumulation. Obesity is a major cause of morbidity and mortality and …

Obesity is a well-known risk factor for the development of insulin resistance, type 2 diabetes,
dyslipidemia, hypertension, and cardiovascular disease. Rather than the total amount of fat …

Obesity, defined as having a body mass index (BMI) greater than 30 kg/m 2, has been
verified to be associated with several health problems which are always grouped as …

Obesity is rapidly dispersing all around the world and is closely associated with a high risk of
metabolic diseases such as insulin resistance, dyslipidemia, and nonalcoholic fatty liver …